Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
James M. Paik, Seema Mir, Saleh A. Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M. Younossi – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common but complex chronic liver disease, driven by environmental and genetic factors. We assessed metabolic and dietary risk factor associations with NAFLD liver mortality using the Global Burden of Disease (GBD) 2017 data. NAFLD liver deaths were calculated (per 100,000) as age‐standardized rates (ASRs) from 195 countries and territories (21 GBD regions; 7 GBD superregions).
PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD
Catherine C. Cohen, Eduardo Castillo‐Leon, Alton B. Farris, Shelley A. Caltharp, Rebecca L. Cleeton, Elizabeth M. Sinclair, Diane E. Shevell, Morten A. Karsdal, Mette Juul Fisker Nielsen, Diana J. Leeming, Miriam B. Vos – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease in children and may lead to cirrhosis requiring liver transplant. Thus, prompt diagnosis of advanced fibrosis is essential.
REPLY:
Mei‐Hsuan Lee, Yi‐Hsiang Huang, Jill Koshiol – 7 July 2021
Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD
Yufeng Hu, Wenzhi He, Yongping Huang, Hui Xiang, Juan Guo, Yan Che, Xu Cheng, Fengjiao Hu, Manli Hu, Tengfei Ma, Jie Yu, Han Tian, Song Tian, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Xiao‐Jing Zhang, Zan Huang, Juan Yang, Hongliang Li – 6 July 2021
Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis
Winnie Y. Zou, Binu E. Enchakalody, Peng Zhang, Nidhi Shah, Sameer D. Saini, Nicholas C. Wang, Stewart C. Wang, Grace L. Su – 6 July 2021 – Body composition measures derived from already available electronic medical records (computed tomography [CT] scans) can have significant value, but automation of measurements is needed for clinical implementation. We sought to use artificial intelligence to develop an automated method to measure body composition and test the algorithm on a clinical cohort to predict mortality.
Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD
Sílvia Vilarinho, Veeral Ajmera, Melanie Zheng, Rohit Loomba – 6 July 2021
A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis
Marina Garcia‐Macia, Adrián Santos‐Ledo, Jack Leslie, Hannah L. Paish, Amy L. Collins, Rebecca S. Scott, Abigail Watson, Rachel A. Burgoyne, Steve White, Jeremy French, John Hammond, Lee A. Borthwick, Jelena Mann, Juan P. Bolaños, Viktor I. Korolchuk, Fiona Oakley, Derek A. Mann – 6 July 2021
Dietary N‐Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA‐Based Study
Jiali Zheng, Carrie R. Daniel, Rikita I. Hatia, Janice Stuff, Ahmed A. Abdelhakeem, Asif Rashid, Yun Shin Chun, Prasun K. Jalal, Ahmed O. Kaseb, Donghui Li, Manal M. Hassan – 6 July 2021
Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
Hans Dieter Nischalke, Alexandra Klüners, Jacob Nattermann, Thomas Berg, Christian P. Strassburg, Philipp Lutz – 6 July 2021